Clinical Trials Directory

Trials / Completed

CompletedNCT03055052

Clinical Effects of a Formula With Modified Protein Levels and Fat Blend in Preterm Infants

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
160 (actual)
Sponsor
Société des Produits Nestlé (SPN) · Industry
Sex
All
Age
33 Weeks
Healthy volunteers
Not accepted

Summary

This study evaluates the effects of infant formula with higher protein level and improved fat blend on growth and feeding tolerance in preterm infants. Half of the subjects will receive a standard infant formula, while the other half will receive a infant formula with a higher protein level and improved fat blend.

Detailed description

When an infant is born prematurely, the supply of nutrients supporting normal growth and development is interrupted. There is less time to accrue adequate nutrient stores and foetal tissue. The nutritional goal for the preterm infant is to have satisfactory functional development and catch up on growth to match the rate of a full term infant. To achieve this, it is recommended for the infant to have adequate protein intake and suitable fat blend.

Conditions

Interventions

TypeNameDescription
OTHERStandard formula for preterm infantsReconstituted in water and given to infants at more than 50% of feedings.
OTHERFormula with higher protein and new fat blend for preterm infantsReconstituted in water and given to infants at more than 50% of feedings.

Timeline

Start date
2017-01-01
Primary completion
2018-03-18
Completion
2018-06-25
First posted
2017-02-16
Last updated
2018-08-03

Locations

1 site across 1 country: Vietnam

Source: ClinicalTrials.gov record NCT03055052. Inclusion in this directory is not an endorsement.